Polytech in $9.7m series-A for Ava

Others contributing to the round were incoming investors Blue Ocean Ventures and Nasdaq-listed media company Global Sources, along with the company's existing seed investors Swisscom and Zürcher Kantonal Bank.

Ava launched its first product, a fertility tracking wearable, in July 2016.

The funding will be used for product development, to scale production of Ava bracelets, and to advance the company's research. The startup also hopes to launch in various European countries early next year.

Previous funding
Ava raised a $2.6m seed round from Zürcher Kantonal Bank and Swisscom Ventures in November 2015.

Company
Founded in 2014 and headquartered in Zurich and San Francisco, Ava is a medical technology company developing a bracelet that aims to detect a woman's fertility window.

The company is also working on clinical studies to expand its algorithms for use in pregnancy recognition, pregnancy monitoring, and possible use as a non-hormonal contraceptive device.

People
Polytech Ventures – Laurent Bischof (managing director).
Ava – Pascal Koenig (founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Healthcare
• Switzerland
• Venture